Expand HOTH Menu
HOTH MENU

HOTH Latest Press Releases

-- March 10, 2026 --

Hoth Therapeutics Reports Positive Female Preclinical Data Showing HT-VA Restores Cholesterol Levels and Improves Lipid Metabolism in MASLD Model PRNewswire 8:13 AM

-- March 4, 2026 --

Hoth Therapeutics Deploys OpenAI API to Advance Development of Orphan HT-KIT Oncology Program PRNewswire 8:31 AM

-- February 24, 2026 --

HOTH THERAPEUTICS ACCELERATES HT-001 TRIAL ENROLLMENT WITH NEW CLINICAL SITE AS PATIENT DEMAND INCREASES PRNewswire 4:15 PM

-- February 10, 2026 --

Hoth Therapeutics Announces Groundbreaking Positive Results: Hoth's HT-VA GDNF Surpasses Semaglutide in Weight Loss, Glucose Control, and Liver Health in Obesity Model PRNewswire 8:30 AM

-- February 5, 2026 --

Hoth Therapeutics Addresses Market Rumor, Hoth Holds No Crypto Currency Assets PRNewswire 8:03 AM

-- January 22, 2026 --

Hoth Therapeutics Delivers 100% Clinical Response with ~50% Reduction in Disease Severity in Open-Label PK Cohort of EGFR-Treated Cancer Patients PRNewswire 8:13 AM

-- January 21, 2026 --

Hoth Therapeutics Secures Major International Patent Milestone for HT-KIT Cancer Program, Strengthening Global Oncology IP Position PRNewswire 8:13 AM

-- January 15, 2026 --

Hoth Therapeutics Reaches Key EU Regulatory Inflection Point Advancing HT-001 Oncology Trial Toward Multi-Country Site Activation PRNewswire 8:17 AM

-- January 2, 2026 --

Hoth Therapeutics Expands Oncology Pipeline with Dual Patent Filings Establishing Novel Oncology Dermatology IP Platform PRNewswire 8:13 AM

-- December 3, 2025 --

Hoth Therapeutics Issues Comprehensive Pipeline Update Highlighting Clinical Progress, Orphan-Designated HT-KIT, Advancing HT-001 Phase 2, and New GDNF Metabolic Program PRNewswire 2:00 PM

-- December 1, 2025 --

Hoth Therapeutics to Present at Noble Capital Markets 21st Annual Emerging Growth Equity Conference, December 2-3, 2025 PRNewswire 8:03 AM

-- November 20, 2025 --

Hoth Therapeutics Accepted Into NVIDIA Connect Program, Expanding Its AI and Accelerated Computing Capabilities PRNewswire 8:13 AM

-- October 27, 2025 --

Hoth Therapeutics Launches VA-Backed Study of Novel GDNF Weight Loss Therapy Targeting Obesity and Fatty Liver Disease PRNewswire 7:49 AM

-- October 21, 2025 --

Hoth Therapeutics Reports FDA Orphan Drug Designation and Strong Preclinical Data for HT-KIT in Rare c-KIT-Driven Cancers PRNewswire 8:23 AM
Market Data Delayed 15 Minutes